Columbia Laboratories Inc. (CBRX) Profile

Profile for Columbia Laboratories Inc. (CBRX)

After Hours: $ 0.78

-0.004 (-0.51%)

Volume: 2.65 k

6:48 PM EST Feb 10, 2012


Business Description: Columbia Laboratories, Inc. is in the business of developing, manufacturing and selling pharmaceutical products that utilize its proprietary bioadhesive drug delivery technologies.

Address:	354 Eisenhower Parkway, Livingston, NJ, 07039
Telephone:	(973) 994-3999	Website:	www.columbialabs.com
Facsimile:	(973) 994-3001	Email:	N/A


Details

CEO:	Mr. Frank C. Condella,Jr
Employees:	22	Market Cap:	68.42 m
Issue Type:	CS
Auditor:	BDO USA, LLP
Last Audit:	Unqualified
Indices:	Drug Delivery


Industry Classifications

Sector:	Healthcare	CIK:	0000821995
Industry:	Drugs
Sub-Industry:	Drug Delivery
NAICS:	Pharmaceutical Preparation Manufacturing (325412)
SIC:	Pharmaceutical Preparations (2834)

Tags for Columbia Laboratories Inc.

Research stocks or mutual funds related to Columbia Laboratories Inc. by keywords or tags. Find companies that have a similar focus to CBRX. The keywords below have been associated to CBRX by either user submission or electronic means.

biotechnology company pharmaceutical market Commercial Physical And Biological Research (8731) pharmaceuticals companies generic pharmaceutical pharmaceutical investment medical product development biotechnology market pharmaceutical research and development drug delivery technologies pharmaceutical manufacturing company female fertility pharma marketing pharmaceutical industry marketing pharmaceutical software pharma manufacturing pharma license progesterone oil low progesterone generic products progesterone cream drug delivery pharmaceutical cro pharma companies pharma consulting clinical trials industry drug delivery market pharmaceutical distributors pharmaceutical labs pharmaceutical development pharmaceutical reports Drugs pregnancy progesterone supplement pharma r&d infertility treatment infertility infertility causes pharmaceutical manufacturing software pharmaceutical manufacturing pharmaceutical formulation contract pharmaceutical pharmaceutical consulting pharmaceutical industry crinone pharmaceutical studies pharmaceutical advances pharmaceutical distributor pharmaceutical out licensing pharmaceutical business development multinational pharmaceutical companies

Financial Market Data powered by QuoteMedia.com. All rights reserved. View the Terms of Use
NYSE/AMEX data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless indicated.
RT Realtime, EOD End Of Day, PD Previous Day. PW Previous Week.

All information displayed and available herein is on an "as is", "as available" basis and neither InvestorPoint.com nor any of its underlying service providers, information providers, licensors, employees, distributors or agents make any representations as to the suitability of our service or the materials for any purpose. The information is not intended for trading purposes or advice. We specifically disclaim any representations or warranties, express or implied, including, without limitation, any representations or warranties of merchantability or fitness for a particular purpose. InvestorPoint.com is not an investment adviser. We do not: (a) give investment advice, (b) advocate the purchase or sale of any security or investment and (c) provide, endorse or review any information or data contained herein. We do not guarantee the accuracy of the information and data supplied by information providers. We are not liable or responsible for the quality, accuracy or reliability of this information. You should always seek the assistance of a professional for investment advice.